{"product_id":"metabolic-syndrome-and-neurological-disorders-9781118395271","title":"Metabolic Syndrome and Neurological Disorders","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003eMetabolic Syndrome and Neurological Disorders compiles data and analyses of the cluster of common pathologies to generate a complete, updated guide to the link between metabolic syndrome and neurological disorders.\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003cp\u003e\u003cb\u003eForeword\u003c\/b\u003e \u003ci\u003eMark P. Mattson\u003c\/i\u003e xi\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePreface\u003c\/b\u003e \u003ci\u003eTahira Farooqui and Akhlaq A. Farooqui\u003c\/i\u003e xiii\u003c\/p\u003e \u003cp\u003e\u003cb\u003eAcknowledgments\u003c\/b\u003e \u003ci\u003eTahira Farooqui and Akhlaq A. Farooqui\u003c\/i\u003e xv\u003c\/p\u003e \u003cp\u003e\u003cb\u003eContributors xvii\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e1 Insulin Resistance and Metabolic Failure Underlie Alzheimer Disease 1\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eSuzanne M. de la Monte and Ming Tong\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e2 Insulin Receptor and the Pathophysiology of Alzheimer Disease 31\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eJohanna Zemva and Markus Schubert\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e3 Contribution of Insulin Resistance in Pathogenesis of Alzheimer Disease 51\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eAdnan Erol\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e4 Insulin–Leptin Signaling in the Brain 75\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eVicente Barrios, Emma Burgos-Ramos, and Jes´us Argente\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e5 The Janus Face of Insulin in Brain 85\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eAna Duarte, Emanuel Candeias, S´onia C. Correia, Renato X. Santos, Cristina Carvalho, Susana Cardoso, Ana I. Pl´acido, Maria S. Santos, Catarina R. Oliveira, and Paula I. Moreira\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e6 Modulation of Cognition by Insulin and Aging: Implications for Alzheimer Disease 115\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eMaite Solas and Maria J. Ram´ýrez\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e7 Contribution of Phospholipid, Sphingolipids, and Cholesterol-Derived Lipid Mediators in the Pathogenesis of Metabolic Syndrome and Neurological Disorders 137\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eAkhlaq A. Farooqui and Tahira Farooqui\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e8 Lipids, Cholesterol, and Oxidized Cholesterol in Alzheimer Amyloid Beta-Mediated\u003c\/b\u003e\u003cbr\u003e \u003cb\u003eNeurotoxicity 163\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eMun’delanji C. Vestergaard, Masamune Morita, Tsutomu Hamada, and Masahiro Takagi\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e9 Of Sound Mind and Body: Dietary Lifestyles, Promotion of Healthy Brain Aging, and Prevention of Dementia in Healthy Individuals 179\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eGiulio Maria Pasinetti, Amanda Bilski, Lap Ho, Jun Wang, Mario Ferruzzi, Masahito Yamada, Kenjiro Ono, and Salvatore Mannino\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e10 Metabolic Syndrome as an Independent Risk Factor of Silent Brain Infarction 191\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eJae-Sung Lim and Hyung-Min Kwon\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e11 Neurochemical Linkage Among Metabolic Syndrome, Alzheimer Disease, and Depression 197\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eUndurti N. Das\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e12 Alterations in the Endocannabinoid System as a Link Between Unbalanced Energy Homeostasis, Neuroinflammation, and Neurological and Neuropsychiatric Disorders 219\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eTiziana Bisogno and Vincenzo Di Marzo\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e13 Metabolic Syndrome, Alzheimer Disease, Schizophrenia, and Depression: Role for Leptin, Melatonin, Kynurenine Pathways, and Neuropeptides 235\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eGeorge Anderson and Michael Maes\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e14 Binge Eating and Metabolic Syndrome 249\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eIgnacio J´auregui-Lobera\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e15 Phytochemical Principles in the Traditional Indian System of Medicine Used for the Management of Metabolic Syndrome 261\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eSyed Ibrahim Rizvi and Neetu Mishra\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e16 Oxidative Stress and Obesity: Their Impact on Metabolic Syndrome 275\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eMorihiro Matsuda and Iichiro Shimomura\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e17 The Relationship Among Obesity, Inflammation, and Insulin Resistance 283\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eJean-Philippe Bastard and Bruno F`eve\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e18 Involvement of Adipocytokines in Pathogenesis of Insulin Resistance, Obesity, and Metabolic Syndrome 297\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eHardik Gandhi and Ramachandran Balaraman\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e19 Obesity, Inflammation, and Vascular Disease: Novel Insight in the Role of Adipose Tissue 311\u003c\/b\u003e\u003cbr\u003e \u003ci\u003ePaolo Calabro, Enrica Golia, Valeria Maddaloni, Giuseppe Limongelli, Brunella Ziello, Fabio Fimiani, Ilaria Jane Romano, Mario Crisci, Maria Giovanna Russo, Edward T.H. Yeh, and Raffaele Calabro\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e20 Is Diabetes a Risk Factor for Parkinson Disease? 327\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eAkhlaq A. Farooqui and Tahira Farooqui\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e21 Role of Iron in the Pathogenesis of Diabetes and Metabolic Syndrome 335\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eLu Cai\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e22 Contributions of AMP Kinase to the Pathogenesis of Type 2 Diabetes and Neurodegenerative Diseases 363\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eMohamed Kodiha, Hicham Mahboubi, and Ursula Stochaj\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e23 A_ Deposition, Insulin Signaling, and Tau Phosphorylation in Animal Models of Alzheimer Disease and Diabetes 383\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eNaoyuki Sato and Ryuichi Morishita\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e24 In Vivo Evidence of the Convergence of Type 2 Diabetes and Alzheimer Disease 395\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eSun Ah Park\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e25 Metabolic Syndrome and its Impact on Cardiovascular Disease 409\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eJohn A. Larry\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e26 Contribution of Inflammation, Adiponectin, and Obesity in Cardiovascular Diseases 423\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eHarald Mangge and Gunter Almer\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e27 Brain and Cardiovascular Diseases: Molecular Aspects 439\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eEwa Szczepanska-Sadowska\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e28 Molecular Aspects of Dietary–Exercise Regimen for the Prevention of Metabolic Syndrome 461\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eWataru Aoi\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e29 Ghrelin, Lipid Metabolism, and Metabolic Syndrome 475\u003c\/b\u003e\u003cbr\u003e \u003ci\u003ePablo B. Mart´ýnez de Morentin, Sulay Tovar, Rub´en Nogueiras, Miguel L´opez, and Carlos Di´eguez\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e30 Leptin and Cognitive Function 485\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eJenni Harvey\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e31 Fructose, Sugar Consumption, and Metabolic Diseases 501\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eVirgile Lecoultre and Luc Tappy\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e32 Inflammation-Mediated Cognitive and Emotional Alterations in Experimental Models of Metabolic Syndrome 515\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eNathalie Castanon and Sophie Lay´e\u003c\/i\u003e\u003cbr\u003e \u003cbr\u003e \u003cb\u003e33 Summary and Perspective 529\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eTahira Farooqui and Akhlaq A. Farooqui\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003eIndex 539\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003eColor plate section is located between pages 196 and 197.\u003c\/i\u003e\u003c\/p\u003e","brand":"John Wiley and Sons Ltd","offers":[{"title":"Default Title","offer_id":49406863966551,"sku":"9781118395271","price":166.46,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9781118395271.jpg?v=1730497374","url":"https:\/\/bookcurl.com\/products\/metabolic-syndrome-and-neurological-disorders-9781118395271","provider":"Book Curl","version":"1.0","type":"link"}